エピネフリン自動注射器の世界市場2023年-2027年

◆英語タイトル:Global Epinephrine Autoinjector Market 2023-2027

Technavioが発行した調査報告書(IRTNTR43297-23)◆商品コード:IRTNTR43297-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年11月25日
◆ページ数:120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Technavio社の市場調査レポートでは、世界のエピネフリン自動注射器市場規模が2022年から2027年まで年平均9.68%成長し、2014.33百万ドルに達すると予測しています。当調査レポートでは、エピネフリン自動注射器の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、過去の市場規模、ファイブフォース分析、投与量別分析(0.30gm、0.15gm、0.50gm)、エンドユーザー別分析(病院、クリニック、在宅医療)、顧客状況、地域別状況(北米、ヨーロッパ、アジア太平洋、アメリカ、ドイツ、イギリス、中国、日本、その他地域)、推進要因・課題・動向、企業状況、企業分析などの内容を掲載しています。なお、当市場の主要企業には、Adamis Pharmaceuticals Corp.、ALK Abello AS、Amneal Pharmaceuticals Inc.、BIOPROJET、Crossject、Halozyme Therapeutics Inc.、kaleo Inc.、Shionogi and Co. Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Windgap Medical Inc.、Bausch Health Co Inc.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・過去の市場規模
・ファイブフォース分析

・世界のエピネフリン自動注射器市場規模:投与量別
- 投与量0.30gmエピネフリン自動注射器の市場規模
- 投与量 0.15gmエピネフリン自動注射器の市場規模
- 投与量0.50gmエピネフリン自動注射器の市場規模

・世界のエピネフリン自動注射器市場規模:エンドユーザー別
- 病院における市場規模
- クリニックにおける市場規模
- 在宅医療における市場規模

・顧客状況

・地域別状況
- 北米のエピネフリン自動注射器市場規模
- ヨーロッパのエピネフリン自動注射器市場規模
- アジア太平洋のエピネフリン自動注射器市場規模
- アメリカのエピネフリン自動注射器市場規模
- ドイツのエピネフリン自動注射器市場規模
- イギリスのエピネフリン自動注射器市場規模
- 中国のエピネフリン自動注射器市場規模
- 日本のエピネフリン自動注射器市場規模
- その他地域のエピネフリン自動注射器市場規模

・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益・価格・競争・プロモーションなどの主要なパラメーターの分析から、複数のソースからのデータを研究、統合、総括の方法により、市場の詳細なイメージを提示します。また、業界における主要インフルエンサーを特定することにより、市場の様々な側面を提供します。提示される情報は包括的​​で信頼性が高く、一次・二次の広範囲な調査結果です。 Technavio社の市場調査レポートは、正確な市場の成長を予測するために、完璧な競争環境と定性的・定量的調査手法を用いた詳細なベンダー選定方法と分析を提供します。

エピネフリン自動注射器の世界市場 2023-2027

Technavio社は、エピネフリン自動注射器市場をモニターしており、2023年から2027年にかけて2,014.33百万ドルの成長が見込まれ、予測期間中のCAGRは9.68%で加速しています。当レポートでは、エピネフリン自動注射器市場について、市場規模や予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析など、包括的な分析を提供しています。

当レポートでは、現在の世界市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、アレルギーの有病率の増加、マーケティング戦略、アナフィラキシーに対する意識の高まり、革新的なエピネフリン自動注射器の利用可能性によって牽引されています。

Technavioのエピネフリン自動注射器市場は以下のようにセグメント化されています:

・用量別:
- 0.30gm
- 0.15gm
- 0.50gm

・エンドユーザー別:
- 病院
- クリニック
- 在宅医療

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

この調査では、今後数年間のエピネフリン自動注射器市場の成長を促進する主な理由の1つとして、暫定的な製品の発売を挙げています。また、エピネフリン自動注射器と患者支援プログラムに関する認知度の高まりは、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、エピネフリン自動注射器市場について以下の分野をカバーしています:
- エピネフリン自動注射器市場のサイジング
- エピネフリン自動注射器市場予測
- エピネフリン自動注射器市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., kaleo Inc., Shionogi and Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Windgap Medical Inc., and Bausch Health Co Incなどの企業情報が含まれています。また、エピネフリン自動注射器市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。この調査レポートは、エピネフリン自動注射器市場を分析し、市場成長に影響を与える今後の動向と課題についての情報を掲載しています。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Dosage
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global epinephrine autoinjector market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global epinephrine autoinjector market 2017 – 2021 ($ million)
o 4.2 Dosage Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Dosage Segment 2017 – 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Dosage
o 6.1 Market segments
o Exhibit 30: Chart on Dosage – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Dosage – Market share 2022-2027 (%)
o 6.2 Comparison by Dosage
o Exhibit 32: Chart on Comparison by Dosage
o Exhibit 33: Data Table on Comparison by Dosage
o 6.3 0.30gm – Market size and forecast 2022-2027
o Exhibit 34: Chart on 0.30gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on 0.30gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on 0.30gm – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on 0.30gm – Year-over-year growth 2022-2027 (%)
o 6.4 0.15gm – Market size and forecast 2022-2027
o Exhibit 38: Chart on 0.15gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on 0.15gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on 0.15gm – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on 0.15gm – Year-over-year growth 2022-2027 (%)
o 6.5 0.50gm – Market size and forecast 2022-2027
o Exhibit 42: Chart on 0.50gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on 0.50gm – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on 0.50gm – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on 0.50gm – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Dosage
o Exhibit 46: Market opportunity by Dosage ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 47: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 48: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 49: Chart on Comparison by End-user
o Exhibit 50: Data Table on Comparison by End-user
o 7.3 Hospitals and clinics – Market size and forecast 2022-2027
o Exhibit 51: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o 7.4 Homecare – Market size and forecast 2022-2027
o Exhibit 55: Chart on Homecare – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Homecare – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Homecare – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Homecare – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 59: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Adamis Pharmaceuticals Corp.
o Exhibit 108: Adamis Pharmaceuticals Corp. – Overview
o Exhibit 109: Adamis Pharmaceuticals Corp. – Business segments
o Exhibit 110: Adamis Pharmaceuticals Corp. – Key offerings
o Exhibit 111: Adamis Pharmaceuticals Corp. – Segment focus
o 12.4 ALK Abello AS
o Exhibit 112: ALK Abello AS – Overview
o Exhibit 113: ALK Abello AS – Product / Service
o Exhibit 114: ALK Abello AS – Key offerings
o 12.5 Amneal Pharmaceuticals Inc.
o Exhibit 115: Amneal Pharmaceuticals Inc. – Overview
o Exhibit 116: Amneal Pharmaceuticals Inc. – Business segments
o Exhibit 117: Amneal Pharmaceuticals Inc. – Key news
o Exhibit 118: Amneal Pharmaceuticals Inc. – Key offerings
o Exhibit 119: Amneal Pharmaceuticals Inc. – Segment focus
o 12.6 Bausch Health Co Inc.
o Exhibit 120: Bausch Health Co Inc. – Overview
o Exhibit 121: Bausch Health Co Inc. – Business segments
o Exhibit 122: Bausch Health Co Inc. – Key news
o Exhibit 123: Bausch Health Co Inc. – Key offerings
o Exhibit 124: Bausch Health Co Inc. – Segment focus
o 12.7 BIOPROJET
o Exhibit 125: BIOPROJET – Overview
o Exhibit 126: BIOPROJET – Product / Service
o Exhibit 127: BIOPROJET – Key offerings
o 12.8 Crossject
o Exhibit 128: Crossject – Overview
o Exhibit 129: Crossject – Product / Service
o Exhibit 130: Crossject – Key offerings
o 12.9 Halozyme Therapeutics Inc.
o Exhibit 131: Halozyme Therapeutics Inc. – Overview
o Exhibit 132: Halozyme Therapeutics Inc. – Product / Service
o Exhibit 133: Halozyme Therapeutics Inc. – Key offerings
o 12.10 kaleo Inc.
o Exhibit 134: kaleo Inc. – Overview
o Exhibit 135: kaleo Inc. – Product / Service
o Exhibit 136: kaleo Inc. – Key offerings
o 12.11 Shionogi and Co. Ltd.
o Exhibit 137: Shionogi and Co. Ltd. – Overview
o Exhibit 138: Shionogi and Co. Ltd. – Product / Service
o Exhibit 139: Shionogi and Co. Ltd. – Key offerings
o 12.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 140: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 141: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 142: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 143: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 144: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.13 Viatris Inc.
o Exhibit 145: Viatris Inc. – Overview
o Exhibit 146: Viatris Inc. – Business segments
o Exhibit 147: Viatris Inc. – Key offerings
o Exhibit 148: Viatris Inc. – Segment focus
o 12.14 Windgap Medical Inc.
o Exhibit 149: Windgap Medical Inc. – Overview
o Exhibit 150: Windgap Medical Inc. – Product / Service
o Exhibit 151: Windgap Medical Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 152: Inclusions checklist
o Exhibit 153: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 154: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 155: Research methodology
o Exhibit 156: Validation techniques employed for market sizing
o Exhibit 157: Information sources
o 13.5 List of abbreviations
o Exhibit 158: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Dosage
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global epinephrine autoinjector market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Dosage Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End user Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Dosage – Market share 2022-2027 (%)
Exhibits31: Data Table on Dosage – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Dosage
Exhibits33: Data Table on Comparison by Dosage
Exhibits34: Chart on 0.30gm – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on 0.30gm – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on 0.30gm – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on 0.30gm – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on 0.15gm – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on 0.15gm – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on 0.15gm – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on 0.15gm – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on 0.50gm – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on 0.50gm – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on 0.50gm – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on 0.50gm – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Dosage ($ million)
Exhibits47: Chart on End-user – Market share 2022-2027 (%)
Exhibits48: Data Table on End-user – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by End-user
Exhibits50: Data Table on Comparison by End-user
Exhibits51: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Homecare – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Homecare – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Homecare – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Homecare – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by End-user ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Adamis Pharmaceuticals Corp. – Overview
Exhibits109: Adamis Pharmaceuticals Corp. – Business segments
Exhibits110: Adamis Pharmaceuticals Corp. – Key offerings
Exhibits111: Adamis Pharmaceuticals Corp. – Segment focus
Exhibits112: ALK Abello AS – Overview
Exhibits113: ALK Abello AS – Product / Service
Exhibits114: ALK Abello AS – Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. – Overview
Exhibits116: Amneal Pharmaceuticals Inc. – Business segments
Exhibits117: Amneal Pharmaceuticals Inc. – Key news
Exhibits118: Amneal Pharmaceuticals Inc. – Key offerings
Exhibits119: Amneal Pharmaceuticals Inc. – Segment focus
Exhibits120: Bausch Health Co Inc. – Overview
Exhibits121: Bausch Health Co Inc. – Business segments
Exhibits122: Bausch Health Co Inc. – Key news
Exhibits123: Bausch Health Co Inc. – Key offerings
Exhibits124: Bausch Health Co Inc. – Segment focus
Exhibits125: BIOPROJET – Overview
Exhibits126: BIOPROJET – Product / Service
Exhibits127: BIOPROJET – Key offerings
Exhibits128: Crossject – Overview
Exhibits129: Crossject – Product / Service
Exhibits130: Crossject – Key offerings
Exhibits131: Halozyme Therapeutics Inc. – Overview
Exhibits132: Halozyme Therapeutics Inc. – Product / Service
Exhibits133: Halozyme Therapeutics Inc. – Key offerings
Exhibits134: kaleo Inc. – Overview
Exhibits135: kaleo Inc. – Product / Service
Exhibits136: kaleo Inc. – Key offerings
Exhibits137: Shionogi and Co. Ltd. – Overview
Exhibits138: Shionogi and Co. Ltd. – Product / Service
Exhibits139: Shionogi and Co. Ltd. – Key offerings
Exhibits140: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits141: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits142: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits143: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits144: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits145: Viatris Inc. – Overview
Exhibits146: Viatris Inc. – Business segments
Exhibits147: Viatris Inc. – Key offerings
Exhibits148: Viatris Inc. – Segment focus
Exhibits149: Windgap Medical Inc. – Overview
Exhibits150: Windgap Medical Inc. – Product / Service
Exhibits151: Windgap Medical Inc. – Key offerings
Exhibits152: Inclusions checklist
Exhibits153: Exclusions checklist
Exhibits154: Currency conversion rates for US$
Exhibits155: Research methodology
Exhibits156: Validation techniques employed for market sizing
Exhibits157: Information sources
Exhibits158: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ エピネフリン自動注射器の世界市場2023年-2027年(Global Epinephrine Autoinjector Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆